Guidelines on the management of irritable bowel syndrome: In memory of Professor Witold Bartnik

Anna Pietrzak; Barbara Skrzydło-Radomańska; Agata Mulak; Michał Lipiński; Ewa Małecka-Panas; Jarosław Reguła; Grażyna Rydzewska

doi:10.5114/pg.2018.78343

Guidelines on the management of irritable bowel syndrome: In memory of Professor Witold Bartnik

Prz Gastroenterol. 2018;13(4):259-288. doi: 10.5114/pg.2018.78343. Epub 2018 Sep 19.

Authors

Anna Pietrzak^{1

2}, Barbara Skrzydło-Radomańska³, Agata Mulak⁴, Michał Lipiński⁵, Ewa Małecka-Panas⁶, Jarosław Reguła^{1

2}, Grażyna Rydzewska^{5

7}

Affiliations

¹ Department of Oncological Gastroenterology, Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology, Warsaw, Poland.
² Department of Gastroenterology, Hepatology and Clinical Oncology, Centre of Postgraduate Medical Education, Warsaw, Poland.
³ Department of Gastroenterology, Medical University of Lublin, Lublin, Poland.
⁴ Department of Gastroenterology and Hepatology, Wroclaw Medical University, Wroclaw, Poland.
⁵ Department of Internal Medicine and Gastroenterology with Inflammatory Bowel Disease Subdivision, Central Clinical Hospital of the Ministry of the Interior, Warsaw, Poland.
⁶ Department of Digestive Tract Diseases, Medical University of Lodz, Lodz, Poland.
⁷ Department of the Prevention of Alimentary Tract Diseases, Faculty of Medicine and Health Science, Jan Kochanowski University, Kielce, Poland.

Abstract

These guidelines constitute an update of the previous "Recommendations on the management of irritable bowel syndrome" issued in 2008. They have been developed by a Task Force organized by the Governing Board of the Polish Society of Gastroenterology. They discuss, with particular emphasis on new scientific data covering papers published since 2008, the aetiology, epidemiology, clinical presentation, diagnostic principles and criteria for the diagnosis, and recommendations for the treatment of irritable bowel syndrome (IBS). The English-language acronym for the syndrome (IBS) has become popular in medical and popular scientific language. It is also widely recognized by patients who identify with this diagnosis. Therefore, in the discussed guidelines, this is what we will use.

Keywords: IBS; IBS treatment; antidepressants; diastolic drugs; guidelines; irritable bowel syndrome; loperamide; macrogols; recommendations; rifaximin α.